Preventing Errors During Sterile Compounding: Taking the Next Steps
More than 90% of hospitalized patients receive some form of intravenous medications or drug infusion therapy during their stay. Unfortunately, this delivery method is not without risks, and errors involving intravenous medications can result in significant patient harm. ISMP’s presentation will address the multi-factorial risks associated with intravenous medications and the need for adoption of proven technologies and best practices to optimize the safety and reliability of sterile compounding. Speakers will discuss safety strategies for infusion therapy and address specific ways to resolve challenges related to operationalizing technology in a variety of pharmacy settings with differing levels of resources.
- Pharmacy Technicians
Following completion of this activity, participants will be able to:
- Describe the evolution of quality and safety in infusion therapy.
- Identify the most common unsafe practices and at-risk behaviors related to the preparation and administration of sterile medications that are associated with patient harm.
- Discuss the implementation of infusion-related technologies (IV workflow systems, barcode verification, gravimetric analysis) designed to support safe practices during sterile compounding.
- List key factors that should be considered when justifying the acquisition of technology to improve the reliability of sterile compounding.
Introduction and Overview:
Allen Vaida, PharmD, FASHP, Executive Vice President, ISMP
Infusion Management: Where Are We in Terms of Safety?
Christina Michalek, BS, FASHP, Medication Safety Specialist, ISMP
Advancing Infusion Safety in the Pharmacy
Amanda McCoy, PharmD, RPh, Clinical Pharmacist, St. Elizabeth Healthcare, Edgewood, KY
Gravimetrics and Justifying Use of Technology in Sterile Compounding
Lindsey Amerine, PharmD, MS, BCPS, Assistant Director, Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC
This activity is funded through an educational grant from BD.
Release Date: February 15, 2018
Expiration Date: February 15, 2020
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, Inc. and ISMP. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-18-077-H05-P/T has been assigned to this knowledge-based home-study CE activity (initial release date 2-15-18). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.5 contact hours of nurse CE credit. Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.